Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Fortrea Holdings Inc. (FTRE : NSDQ)

• Company Description    Fortrea Holdings Inc. is a provider of clinical development and patient access solutions to the life sciences industry. It provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions and post-approval services. Fortrea Holdings Inc. is based in DURHAM, N.C. Number of Employees: 15,500

• Price / Volume Information    Yesterday's Closing Price: $11.25 Daily Weekly Monthly 20 Day Moving Average: 1,242,145 shares Shares Outstanding: 92.40 (millions) Market Capitalization: $1,039.50 (millions) Beta: 1.86 52 Week High: $25.28 52 Week Low: $3.97 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 16.28% 13.23% 12 Week 39.92% 34.12% Year To Date -39.68% -47.27%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 8 MOORE DRIVE - DURHAM,NC 27709 USA ph: 877-495-0816 fax: - investors@fortrea.com http://www.fortrea.com

• General Corporate Information    Officers Thomas Pike - Chief Executive Officer;President and Chairman Jill McConnell - Chief Financial Officer Robert Parks - Chief Accounting Officer Peter M. Neupert - Director Edward Pesicka - Director Peer Information Fortrea Holdings Inc. (CORR.) Fortrea Holdings Inc. (RSPI) Fortrea Holdings Inc. (CGXP) Fortrea Holdings Inc. (BGEN) Fortrea Holdings Inc. (GTBP) Fortrea Holdings Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 34965K107 SIC: 8071 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/02/26 Share - Related Items Shares Outstanding: 92.40 Most Recent Split Date: (:1) Beta: 1.86 Market Capitalization: $1,039.50 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.15 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.48 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 43.31% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/02/26

• Fundamental Ratios P/E Current FY Estimate: 23.32 Trailing 12 Months: 22.06 PEG Ratio: 0.54 Price Ratios Price/Book: 1.76 Price/Cash Flow: 7.16 Price / Sales: 0.38 EPS Growth vs. Year Ago Period: -47.83% vs. Previous Quarter: -36.84% Sales Growth vs. Year Ago Period: 3.91% vs. Previous Quarter: -1.27% ROE 09/30/25 - 5.64 06/30/25 - 5.25 03/31/25 - 2.84 ROA 09/30/25 - 1.56 06/30/25 - 1.72 03/31/25 - 1.06 Current Ratio 09/30/25 - 1.00 06/30/25 - 1.02 03/31/25 - 0.97 Quick Ratio 09/30/25 - 1.00 06/30/25 - 1.02 03/31/25 - 0.97 Operating Margin 09/30/25 - 1.73 06/30/25 - 2.08 03/31/25 - 1.37 Net Margin 09/30/25 - -36.77 06/30/25 - -37.57 03/31/25 - -29.43 Pre-Tax Margin 09/30/25 - -37.04 06/30/25 - -37.66 03/31/25 - -27.83 Book Value 09/30/25 - 6.40 06/30/25 - 6.51 03/31/25 - 9.49 Inventory Turnover 09/30/25 - - 06/30/25 - - 03/31/25 - - Debt-to-Equity 09/30/25 - 1.81 06/30/25 - 1.87 03/31/25 - 1.22 Debt-to-Capital 09/30/25 - 64.43 06/30/25 - 65.14 03/31/25 - 55.01

Powered by Zacks Investment Research ©